IPO
-
-
-
-
-
-
-
NeuroSense Therapeutics, Ltd. Announces the Presentation of Phase IIa Study Results at Four International Conferences
-
-
-
-
-
-
-
NeuroSense Therapeutics (NRSN) Files IPO Registration Statement
118,853 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

